Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#121 / 200 Total
FLL - Full House Resorts, Inc - Stock Price Chart
TickerFLL [NASD]
CompanyFull House Resorts, Inc
CountryUSA
IndustryResorts & Casinos
Market Cap89.73MEPS (TTM)-1.12
P/E-EPS this Y28.02%
Forward P/E-EPS next Y-0.02%
PEG-EPS past 5Y-
P/S0.30EPS next 5Y0.16%
P/B35.31EPS Q/Q0.84%
Dividend-Sales Q/Q3.37%
Insider Own7.57%Inst Own40.44%
Insider Trans0.00%Inst Trans-1.53%
Short Float2.03%EarningsMar 05/a
Analyst Recom1.80Target Price3.80
Avg Volume139.59K52W Range2.02 - 4.95
Full House Resorts, Inc. engages in the ownership, leasing, development, operation, and management of gaming, hospitality, and entertainment facilities. It operates through the following segments: Midwest & South, West, and Contracted Sports Wagering. The Midwest & South segment includes Silver Slipper, Rising Star and American Place. The West segment includes Chamonix, Bronco Billy's, Grand Lodge, and Stockman's. The Contracted Sports Wagering segment consists of on-site and online sports wagering skins in Colorado, Indiana and Illinois. The company was founded on January 5, 1987 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Guidroz ElaineSVP Secretary, General CounselMar 16 '26Option Exercise1.7040,00068,000121,662Mar 18 06:01 PM
Caracciolo Kathleen MDirectorMar 12 '26Option Exercise1.705,88810,01067,321Mar 16 05:17 PM
Green Eric JDirectorAug 13 '25Buy3.5410,00035,368233,959Aug 14 07:24 PM
LEE DANIEL RChief Executive OfficerJun 13 '25Buy4.75184,200874,950317,145Jun 17 04:20 PM
LEE DANIEL RChief Executive OfficerJun 13 '25Buy4.7592,100437,4751,076,718Jun 17 04:20 PM
GRO - Brazil Potash Corp - Stock Price Chart
TickerGRO [AMEX]
CompanyBrazil Potash Corp
CountryCanada
IndustryOther Industrial Metals & Mining
Market Cap166.07MEPS (TTM)-1.80
P/E-EPS this Y52.85%
Forward P/E-EPS next Y27.59%
PEG-EPS past 5Y-30.32%
P/S-EPS next 5Y31.23%
P/B0.76EPS Q/Q76.75%
Dividend-Sales Q/Q-
Insider Own27.01%Inst Own19.97%
Insider Trans-20.91%Inst Trans-5.78%
Short Float0.74%EarningsNov 13/b
Analyst Recom1.00Target Price12.00
Avg Volume813.10K52W Range1.25 - 3.99
Brazil Potash Corp. is a mineral exploration and development company. Its projects include the Autazes Project, located in the state of Amazonas, Brazil. Brazil Potash technical operations are based in Autazes, Amazonas, Brazil and Belo Horizonte, Minas Gerais and Brazil. The company was founded on October 10, 2006 and is headquartered in Toronto, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SENTIENT EXECUTIVE GP III, LTD10% OwnerNov 12 '25Sale2.003,863,8727,727,7440Nov 14 08:17 AM
PALI - Palisade Bio Inc - Stock Price Chart
TickerPALI [NASD]
CompanyPalisade Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap301.91MEPS (TTM)-1.48
P/E-EPS this Y23.33%
Forward P/E-EPS next Y-27.95%
PEG-EPS past 5Y88.75%
P/S-EPS next 5Y-14.47%
P/B2.24EPS Q/Q98.00%
Dividend-Sales Q/Q-
Insider Own3.75%Inst Own81.84%
Insider Trans0.07%Inst Trans131.39%
Short Float16.14%EarningsMar 25
Analyst Recom1.00Target Price11.50
Avg Volume4.13M52W Range0.53 - 2.64
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jones Mitchell LawrenceChief Medical OfficerFeb 12 '26Sale1.751,9893,48113,263Feb 13 08:10 PM
Finley John DavidCEO, CFOFeb 12 '26Sale1.753,8966,81827,353Feb 13 08:07 PM
Williams Donald AllenDirectorJan 16 '26Buy1.675,0008,35610,728Jan 21 04:05 PM
Williams Donald AllenDirectorJan 09 '26Buy1.885,0009,4005,728Jan 13 09:43 PM
CARL - Carlsmed Inc - Stock Price Chart
TickerCARL [NASD, RUT]
CompanyCarlsmed Inc
CountryUSA
IndustryHealth Information Services
Market Cap238.98MEPS (TTM)-1.15
P/E-EPS this Y27.83%
Forward P/E-EPS next Y3.53%
PEG-EPS past 5Y-
P/S4.73EPS next 5Y19.70%
P/B2.41EPS Q/Q-81.85%
Dividend-Sales Q/Q61.19%
Insider Own66.35%Inst Own12.83%
Insider Trans-1.10%Inst Trans0.08%
Short Float8.64%EarningsFeb 25/a
Analyst Recom1.00Target Price19.20
Avg Volume125.34K52W Range8.86 - 17.19
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. Its solutions are utilized as an information database for surgeons using traditional surgical techniques. The company was founded by Mike Cordonnier and Niall Casey and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cordonnier MichaelCEO, PresidentMar 03 '26Option Exercise1.02193,831198,5551,550,477Mar 04 04:05 PM
Cordonnier MichaelCEO, PresidentMar 02 '26Option Exercise0.34197,85566,2811,554,501Mar 04 04:05 PM
Cordonnier MichaelCEO, PresidentMar 02 '26Sale13.29197,8552,629,8891,356,646Mar 04 04:05 PM
Cordonnier MichaelOfficerMar 02 '26Proposed Sale13.29197,8552,629,881Mar 02 04:54 PM
B CAPITAL GROUP MANAGEMENT, L.10% OwnerJul 24 '25Buy15.001,333,33319,999,9955,013,839Jul 24 08:51 PM
LFS - Leifras Co Ltd ADR - Stock Price Chart
TickerLFS [NASD]
CompanyLeifras Co Ltd ADR
CountryJapan
IndustryEntertainment
Market Cap54.15MEPS (TTM)0.11
P/E18.03EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.70EPS next 5Y-
P/B4.41EPS Q/Q5.32%
Dividend-Sales Q/Q10.69%
Insider Own-Inst Own0.20%
Insider Trans-Inst Trans39.36%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume498.14K52W Range1.58 - 12.49
Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.
BBNX - Beta Bionics Inc - Stock Price Chart
TickerBBNX [NASD, RUT]
CompanyBeta Bionics Inc
CountryUSA
IndustryMedical Devices
Market Cap393.23MEPS (TTM)-1.68
P/E-EPS this Y-9.09%
Forward P/E-EPS next Y-1.43%
PEG-EPS past 5Y-
P/S3.92EPS next 5Y7.91%
P/B1.37EPS Q/Q27.05%
Dividend-Sales Q/Q57.15%
Insider Own22.22%Inst Own96.95%
Insider Trans-0.54%Inst Trans-0.08%
Short Float22.01%EarningsApr 21/a
Analyst Recom1.55Target Price23.09
Avg Volume1.18M52W Range9.37 - 32.71
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hopman MarkChief Commercial OfficerDec 04 '25Sale30.662,06163,192136,216Mar 16 07:55 PM
Hopman MarkChief Commercial OfficerDec 02 '25Sale29.3485625,112138,277Mar 16 07:55 PM
Russell Steven JonChief Medical OfficerDec 02 '25Sale29.341,02530,069178,071Mar 16 07:55 PM
Hopman MarkChief Commercial OfficerMar 04 '26Sale11.573534,084139,133Mar 05 07:30 PM
Mark HopmanOfficerMar 04 '26Proposed Sale11.573534,084Mar 04 06:02 PM
BTBD - BT Brands Inc - Stock Price Chart
TickerBTBD [NASD]
CompanyBT Brands Inc
CountryUSA
IndustryRestaurants
Market Cap9.62MEPS (TTM)-0.11
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.71EPS next 5Y-
P/B1.55EPS Q/Q15.74%
Dividend-Sales Q/Q-17.38%
Insider Own48.77%Inst Own4.11%
Insider Trans0.00%Inst Trans32.61%
Short Float5.27%Earnings-
Analyst Recom-Target Price-
Avg Volume332.94K52W Range1.00 - 5.60
BT Brands, Inc. engages in the owning and operation of quick service restaurants. It operates Burger Time restaurants and a Dairy Queen franchise. Its Burger Time restaurants sell chicken and pulled pork sandwiches, side dishes, and soft drinks. The company was founded in August 1987 and is headquartered in Minnetonka, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gary CopperudDIRECTOROct 10 '25Proposed Sale1.981,033,5402,046,409Oct 02 05:02 PM
COYA - Coya Therapeutics Inc - Stock Price Chart
TickerCOYA [NASD]
CompanyCoya Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap97.82MEPS (TTM)-1.20
P/E-EPS this Y-28.91%
Forward P/E-EPS next Y30.37%
PEG-EPS past 5Y-75.69%
P/S12.30EPS next 5Y13.80%
P/B2.03EPS Q/Q-56.28%
Dividend-Sales Q/Q202768.80%
Insider Own5.69%Inst Own33.91%
Insider Trans0.00%Inst Trans16.99%
Short Float3.99%EarningsMar 16/b
Analyst Recom1.00Target Price15.64
Avg Volume181.68K52W Range3.71 - 7.75
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GOLDSTEIN DOV A MDDirectorAug 18 '25Option Exercise1.0917,55719,13727,557Aug 19 04:01 PM
CYCN - Cyclerion Therapeutics Inc - Stock Price Chart
TickerCYCN [NASD]
CompanyCyclerion Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap12.60MEPS (TTM)-1.18
P/E-EPS this Y10.45%
Forward P/E-EPS next Y17.50%
PEG-EPS past 5Y53.53%
P/S6.09EPS next 5Y-
P/B1.22EPS Q/Q-200.43%
Dividend-Sales Q/Q-43.24%
Insider Own30.84%Inst Own4.55%
Insider Trans0.00%Inst Trans1.70%
Short Float3.78%EarningsMar 25
Analyst Recom1.00Target Price8.00
Avg Volume4.72M52W Range1.03 - 8.48
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
TVTX - Travere Therapeutics Inc - Stock Price Chart
TickerTVTX [NASD, RUT]
CompanyTravere Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.67BEPS (TTM)-0.60
P/E-EPS this Y213.04%
Forward P/E13.62EPS next Y548.79%
PEG-EPS past 5Y30.85%
P/S5.44EPS next 5Y-
P/B22.93EPS Q/Q66.42%
Dividend-Sales Q/Q73.41%
Insider Own1.89%Inst Own113.36%
Insider Trans-28.89%Inst Trans1.67%
Short Float14.86%EarningsFeb 19/a
Analyst Recom1.27Target Price42.50
Avg Volume1.88M52W Range13.14 - 42.13
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baynes Roy D.DirectorApr 06 '26Option Exercise26.5210,000265,20047,500Apr 07 06:17 PM
Baynes Roy D.DirectorApr 06 '26Sale33.0010,000330,00037,500Apr 07 06:17 PM
ROY BAYNESDirectorApr 06 '26Proposed Sale33.0010,000330,000Apr 06 04:06 PM
Dube Eric MCHIEF EXECUTIVE OFFICERApr 01 '26Option Exercise15.4660,000927,600492,886Apr 02 05:55 PM
Dube Eric MCHIEF EXECUTIVE OFFICERApr 01 '26Sale30.9360,0001,855,839432,886Apr 02 05:55 PM
18910111213141516171820